top of page


Generate Biomedicines’ IPO
By Shahmir Ahmed, Alp Ceylan, and Francesco del Sesto (Bocconi University); Diana Usova, Dylan Stiassny, Oli Cedar, Obianuju Okafor (University of Bristol) Photo: Volodymyr Hryshchenko (Unsplash) Summary of IPO As the pharmaceutical industry looks to artificial intelligence to accelerate drug discovery, Generate Biomedicines are positioning themselves as a force to be reckoned with in this growing market. Through what the company has dubbed “Generative Biology”, millions of p
amansp2006
Mar 234 min read


Bain Capital’s $5.3bn Acquisition of Guidehouse
By Jian Wee Soh, Kai Ye, Bharath Sivakumar, Aaren Tan, Arfred Garcia (Imperial College London), Devina Aggarwal, Atin Narain, Omar Ali,...
Victor Paquet
Jan 11, 20246 min read


Xylem’s $7.5bn Acquisition of Evoqua
By Jack Lee, Heather Leung and Sissi Zeng (HKUST), Rhys Meredith, Kian Patel, Oliver Platts, Samuel McCrea, Velizar Zlatev and Salah...

The MergerSight Group
Mar 15, 20235 min read


X-energy’s $2.3bn SPAC Merger with Ares Acquisition Corp.
By Sean Millar, Matthew Moran and Pramoth Ragavan (University of St Andrews), and Adil Amlaiky (McGill University) Photo: Hal Gatewood...

The MergerSight Group
Mar 3, 20235 min read
bottom of page
